189330 — XIIlab Co Share Price
- KR₩41bn
- KR₩33bn
- KR₩4bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 3.71 | ||
Price to Tang. Book | 3.73 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 7.19 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -57.76% | ||
Return on Equity | -48.2% | ||
Operating Margin | -127.14% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 7,089.21 | 11,162.21 | 5,777.88 | 9,896.93 | 3,663.44 | n/a | n/a | -6.46% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | +1011.27 | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
XIIlab Co.,Ltd. is a Korea-based company mainly engaged in the development and sale of software. Along with subsidiaries, the Company operates its business through four segments. The Big Data Regional Information Service segment provides solutions for regional commercial revitalization. The Social Big Data Analysis Service segment provides social big data analysis services through integrated monitoring of social networking service (SNS). The Internet Of Things (IoT)/ Energy Management System (EMS) Big Data Analysis Service segment provides the big data analysis platforms, which is the energy management tools. The Big Data Analysis Education Service segment is involved in the provision of big data related online and offline education services through big data education programs.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- July 27th, 2010
- Public Since
- December 24th, 2013
- No. of Shareholders
- 11,613
- No. of Employees
- 77
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 6,092,284
- Address
- 3/4F, 617, Eonju-ro, Gangnam-gu, SEOUL, 06107
- Web
- https://www.xiilab.com/
- Phone
- +82 220393145
- Auditors
- Dong-A & Song-Kang Accounting Corp
Upcoming Events for 189330
Similar to 189330
Action Square Co
Korea Exchange - KOSDAQ
Actoz Soft Co
Korea Exchange - KOSDAQ
Ahnlab
Korea Exchange - KOSDAQ
Alchera
Korea Exchange - KOSDAQ
Alticast
Korea Exchange - KOSDAQ
FAQ
As of Today at 23:13 UTC, shares in XIIlab Co are trading at KR₩6,740. This share price information is delayed by 15 minutes.
Shares in XIIlab Co last closed at KR₩6,740 and the price had moved by -40.88% over the past 365 days. In terms of relative price strength the XIIlab Co share price has underperformed the FTSE Developed Asia Pacific Index by -47.55% over the past year.
There is no consensus recommendation for this security.
Find out moreXIIlab Co does not currently pay a dividend.
XIIlab Co does not currently pay a dividend.
XIIlab Co does not currently pay a dividend.
To buy shares in XIIlab Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩6,740, shares in XIIlab Co had a market capitalisation of KR₩41bn.
Here are the trading details for XIIlab Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 189330
Based on an overall assessment of its quality, value and momentum XIIlab Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like XIIlab Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -41.88%.
As of the last closing price of KR₩6,740, shares in XIIlab Co were trading -32.32% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The XIIlab Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩6,740.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on XIIlab Co's directors